Comparison table : Triptans
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
The Medical letter on drugs and therapeutics - 65(2023), 1678 vom: 12. Juni, Seite e97-e99 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.06.2023 Date Revised 05.06.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.58347/tml.2023.1678b |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357690257 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357690257 | ||
| 003 | DE-627 | ||
| 005 | 20231226073133.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.58347/tml.2023.1678b |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1192.xml |
| 035 | |a (DE-627)NLM357690257 | ||
| 035 | |a (NLM)37266988 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Comparison table |b Triptans |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.06.2023 | ||
| 500 | |a Date Revised 05.06.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Frova | |
| 650 | 4 | |a Imitrex | |
| 650 | 4 | |a Maxalt | |
| 650 | 4 | |a Onzetra Xsail | |
| 650 | 4 | |a Relpax | |
| 650 | 4 | |a Tosymra | |
| 650 | 4 | |a Zembrace | |
| 650 | 4 | |a adverse effects | |
| 650 | 4 | |a almotriptan | |
| 650 | 4 | |a dosage | |
| 650 | 4 | |a drug interactions | |
| 650 | 4 | |a eletriptan | |
| 650 | 4 | |a frovatriptan | |
| 650 | 4 | |a migraine | |
| 650 | 4 | |a naratriptan | |
| 650 | 4 | |a propranolol | |
| 650 | 4 | |a rizatriptan | |
| 650 | 4 | |a safety | |
| 650 | 4 | |a sumatriptan | |
| 650 | 7 | |a Tryptamines |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The Medical letter on drugs and therapeutics |d 1965 |g 65(2023), 1678 vom: 12. Juni, Seite e97-e99 |w (DE-627)NLM000074810 |x 1523-2859 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2023 |g number:1678 |g day:12 |g month:06 |g pages:e97-e99 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.58347/tml.2023.1678b |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2023 |e 1678 |b 12 |c 06 |h e97-e99 | ||